Hester Biosciences board approves unaudited financial results

31 Oct 2020 Evaluate

Hester Biosciences has informed that pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors in their Meeting held today, have approved the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended on 30.09.2020. The Company enclosed the approved Standalone and Consolidated Unaudited Financial Results and Limited Review Reports; and Press Release issued in this regard. The Company would be publishing the extract of results in the newspaper as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board Meeting commenced at 10:30 am and concluded at 11:05 am.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1630.00 5.45 (0.34%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.